Navigation Links
Loyola's on-site cardiology team dramatically improves care for heart attack patients
Date:4/7/2011

MAYWOOD, Ill. -- The availability of an in-house, around-the-clock interventional cardiology team dramatically decreases the time it takes to restore blood flow to heart attack patients, according to data presented this week. These findings were reported by researchers from Loyola University Health System (LUHS) at the American College of Cardiology annual meeting in New Orleans.

In April 2009, Loyola became the first hospital in Illinois to launch a Heart Attack Rapid Response Team (HARRT). This group includes an interventional cardiologist, a nurse and other members of the cardiac catheterization team who are available at the hospital 24 hours a day, seven days a week. Most hospitals do not have such teams on site during nights and weekends.

"Valuable time is lost when nurses, doctors and technicians have to be called in from home," said interventional cardiologist John Lopez, MD, study investigator and HARRT co-director, LUHS. "Our staff is on hand and prepared all of the time to meet patients when they arrive and require immediate care."

A task force of the American College of Cardiology and American Heart Association recommends that patients undergoing heart attacks receive balloon angioplasties as soon as possible or within 90 minutes of arriving at the hospital -- known as the "door-to-balloon" time.

These data revealed Loyola has far exceeded this standard since the HARRT program launched, with a median door-to-balloon time of just 47 minutes. All patients received angioplasties within 90 minutes and 82 percent received them within 60 minutes. These results greatly exceed the national standards and results from the best hospitals in the country.

During a heart attack, a blockage in an artery stops blood flow. Heart muscle begins to die due to lack of blood and oxygen. But a balloon angioplasty, if done in time, can stop a heart attack by restoring blood flow.

"Having a team on site 24/7 is the bes
'/>"/>

Contact: Nora Plunkett
nplunkett@lumc.edu
708-216-6268
Loyola University Health System
Source:Eurekalert

Page: 1 2

Related medicine news :

1. International Hemp Expo Has On-Site Consumption Covered
2. Doctors use ultrasound to diagnose possible muscular trauma in professional athletes on-site
3. As Popularity of Dental Implants Rise, a Chicago Cosmetic Dentistry Practice's On-site Lab Offers Patients a Unique Incentive
4. 100 Day Countdown to the World Congress of Cardiology Scientific Sessions 2010
5. TCT 2010 to have significant impact on interventional cardiology practices and patient care
6. TCT 2010 to have significant impact on interventional cardiology practices and patient care
7. European Society of Cardiology launches heart-friendly cookery book
8. TCT 2010 late breaking trials to have impact on practice of interventional cardiology
9. Elsevier announces new partnership with CCS to publish the Canadian Journal of Cardiology
10. Canadian Journal of Cardiology publishes advice on genetic testing of inherited cardiac arrhythmias
11. CustomerCentric Selling Helps BCC Software Dramatically Boost Sales Performance and Produce Record Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Healthcare professionals who are looking for ... home or on-the-go via laptops, tablets or mobile ... premium Seminar-on-Demand CE courses. The new courses add ... hours of CE course offerings, allowing therapy ... such a diverse library, there’s something for everyone. ...
(Date:10/22/2014)... King of Prussia, PA (PRWEB) October 22, 2014 ... Group, is recognized as an industry leader with over ... industry award winning team leader in the areas related ... In addition, Mr. Carlson is an Editorial Advisory Board ... Group Healthcare Council Educator. Blue Fin Group is ...
(Date:10/22/2014)... Two sisters in high school have developed ways to ... Krishen use electronic stethoscopes, which electronically amplify body sounds, ... or heartbeats. Ilina, a senior at Port Huron ... way to detect early lung damage in people exposed ... recorded one breath cycle each from 16 smokers, 25 ...
(Date:10/22/2014)... Thompson HealthDay Reporter , MONDAY, ... Monday officially tightened guidelines for health workers treating Ebola patients, ... use of a respirator at all times. The U.S. ... tougher rules after two Dallas nurses contracted Ebola while caring ... Liberian national Thomas Eric Duncan. Nina Pham is currently being ...
(Date:10/20/2014)... Allegheny General Hospital’s (AGH) Cardiovascular Institute is ... repair a damaged mitral valve as the heart continues ... by Abbott Vascular , is designed to treat ... in which the heart’s mitral valve leaflets fail to ... heart’s left ventricle into the left atrium. The heart ...
Breaking Medicine News(10 mins):Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3
... 21 Patient Safety Week was March 8-14. ... (1979), the pulse oximeter (1983) and the brain activity ... of these technological devices clearly improved patient safety. This ... a forward thinking, caring physician."Until now, I,ve never publicly ...
... MI based company, is researching and developing decontamination testing equipment ... use their extensive knowledge of cleaning and decontamination to develop repeatable ... ... (Vocus) April 21, 2009 -- Midbrook, Inc ., a Jackson, ...
... medical billing company, announces services that help medical professionals go paperless, ... the healthcare industry. , ... (PRWEB) April 21, 2009 ... upon the nation,s healthcare system to step up efforts to convert ...
... worldwide for self-directed home treatment of the most common cause of ... ... Edmonton, Canada (PRWEB) April 14, 2009 -- A new ... treatment of BPPV (Benign Paroxysmal Positional Vertigo), the most common ...
... 21 The University HealthSystem Consortium (UHC) today ... for employee satisfaction surveys and consulting services to ... agreement, which has 2 optional 1-year renewal periods, ... an extensive array of customized surveys and analyses ...
... the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory ... of supplemental new drug applications (sNDA) for SEROQUEL XR (quetiapine ... disorder (MDD) and generalized anxiety disorder (GAD).The Advisory Committee concluded: ... SEROQUEL XR was shown to be ...
Cached Medicine News:Health News:American Society of Anesthesiologists Recent Public Debate Comes to Dead End 2Health News:American Society of Anesthesiologists Recent Public Debate Comes to Dead End 3Health News:Midbrook Tackles Medical Decontamination 2Health News:Midbrook Tackles Medical Decontamination 3Health News:Dr. America Comes to Obama's Aid, Helps Doctors Digitize 2Health News:Canadian Medical Device Set to Speed Treatment and Cut Health Care Costs for Common Cause of Vertigo 2Health News:Canadian Medical Device Set to Speed Treatment and Cut Health Care Costs for Common Cause of Vertigo 3Health News:University HealthSystem Consortium Selects Morehead to Provide Employee Satisfaction and Consulting Services 2Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 2Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 3Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 4Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 5Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 6Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 7
(Date:10/22/2014)... -- Sanomedics International Holdings, Inc. (OTCQB: SIMH) – According ... Data Services, demand for thermometers is expected to grow ... demand for more accurate digital thermometers continues.  ... market for thermometers, and one of the companies serving ... Inc. Sanomedics International Holdings designs, develops, markets, ...
(Date:10/22/2014)... Provectus Biopharmaceuticals, Inc. (NYSEMKT: PVCT) specializes in ... drug for cancer, is designed for injection into solid ... oncology focus is on melanoma, breast cancer and cancers ... of PV-10 as a therapy for metastatic melanoma, and ... and psoriasis. This summer, the Company ...
(Date:10/22/2014)... , Oct. 22, 2014  Regulus ... a biopharmaceutical company leading the discovery and ... announced that it has demonstrated human proof-of-concept ... clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated ... of hepatitis C virus infection ("HCV").  Interim ...
Breaking Medicine Technology:Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8
... 27, 2011 As a result of the flagging ... dangerous to their health, according to Consumer Reports, annual ... take a prescription medicine told pollsters they,d cut health-care ... or medical procedure, declining tests, or ordering cheaper drugs ...
... ( http://www.myprgenie.com ) --  Texans for Stem Cell Research ... panel of stem cell experts from Texas and around ... TSCR Second Annual Educational Symposium with a welcome address ... Health Affairs for The University of Texas System. The ...
Cached Medicine Technology:Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 2Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 3Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 4Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 5World-Class Stem Cell Pioneers Collaborate & Educate at Texans for Stem Cell Research 2nd Annual Symposium In Austin 2World-Class Stem Cell Pioneers Collaborate & Educate at Texans for Stem Cell Research 2nd Annual Symposium In Austin 3World-Class Stem Cell Pioneers Collaborate & Educate at Texans for Stem Cell Research 2nd Annual Symposium In Austin 4World-Class Stem Cell Pioneers Collaborate & Educate at Texans for Stem Cell Research 2nd Annual Symposium In Austin 5
Malaria device / strip (3 line, P.f/P.v Ag Test-pLDH)...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
BioSign® Malaria - Rapid Malaria Antigen Test...
Medicine Products: